- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02501512
Maturational Changes in Newborn Infants
Maturational Changes in Coordination of Breathing, Heart Rate and Swallowing in Newborn Infants - a Single-centre Pilot Study
Study Overview
Status
Conditions
Detailed Description
Coordination of respiration, heart rate and swallowing in preterm and term neonates has been subject of various studies in the past; its impeccable functioning is a key criterion to be fulfilled before infants are discharged home from the NICU. Whether coordination abilities depend only on gestational age and how they can be diagnosed objectively remains controversial. Also, the ideal time point of starting to introduce suck feeds and to challenge coordination of breathing and swallowing is unknown and largely remains a matter of trial and error with the risk of causing iatrogenic aspirations of milk if babies are not ready for suck feeds. Successful coordination of swallowing and breathing is generally considered as a higher neurological function and it does represent a mile stone in overall child development. Therefore, measurement of its level of functioning could have the potential to serve as a predictor for neurological outcome. However, it is yet unknown to what extent difficulties in preterm infants allow predictions concerning their neurological development and future outcome. One of the major reasons for these unsolved questions lies in the lack of diagnostic tools to objectively measure suck-swallow-breathing coordination with sufficient accuracy, which make a precise analysis of coordination patterns in preterm infants almost impossible. Considering the relevance of these questions, it seems important to develop tools to observe coordination of breathing, heart rate and swallowing in neonates with possibly greater accuracy.
In this single-centre pilot study 15 preterm infants of 32 to 42 weeks gestational age will be included. Transesophageal ECG and EMG signals will be measured using an Edi-gastric tube (Maquet, Getinge Group, Solna Sweden), a CE-certified neonatal gastric tube equipped with electrodes. Due to the proximity of the esophageal electrodes within the gastric tube to the heart and diaphragm, esophageal ECG and EMG signals can be acquired and are probably less susceptible to motion artefacts of the baby than the commonly used skin electrodes. This is well known from measurements in adults. Moreover, motion of esophageal electrodes due to peristalsis, respiration and cardiac motion superimposes the ECG as baseline wander and might be a surrogate for the coordination abilities of preterm infants.
Using these novel esophageal data this study's goal is to obtain objective data representing maturational patterns of breathing, heart rate, and swallowing in preterm infants. Possibly derived coordination patterns might help to guide nurses and clinicians to introduce suck feeds and to develop specific early intervention strategies. Furthermore, if the gastric tube-EMG proves to be accessible in real time, it could potentially replace standard monitoring tools that require the use of skin electrodes in the future. This would not only facilitate nursing and preserve skin integrity but also simplify bonding between the parents and their infants in the NICU.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Basel Stadt
-
Basel, Basel Stadt, Switzerland, 4056
- University Children's Hospital Basel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Informed Consent by legal representatives as documented by signature
- Gestational age of 32 to 42 weeks
- Study start possible in the course of participant's 4th-10th day of life
- Presumed NICU stay ≥ 5 days from study start onwards
- Need for a gastric feeding tube for clinical reasons for ≥ 5 days from study start onwards
Exclusion Criteria:
- Major congenital malformations
- Circulatory instability (in need of therapy with vasoactive substances)
- Endotracheal ventilation
- Infant in extremis
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Respiratory rate determined by transoesophageal EMG
Time Frame: 5 consecutive days during first two weeks of life
|
5 consecutive days during first two weeks of life
|
|
Heart rate determined by transoesophageal ECG
Time Frame: 5 consecutive days during first two weeks of life
|
5 consecutive days during first two weeks of life
|
|
Swallowing act determined by transoesophageal EMG
Time Frame: 5 consecutive days during first two weeks of life
|
5 consecutive days during first two weeks of life
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Agreement of beat-to-beat heart rate (inter-beat-interval) obtained from EMG signals with corresponding values from NICU monitoring
Time Frame: 5 consecutive days during first two weeks of life
|
To find out whether oesophageal data has the potential to replace standard NICU monitoring.
|
5 consecutive days during first two weeks of life
|
|
Change of average value of respiratory rate over the measurement period
Time Frame: 5 consecutive days during first two weeks of life
|
To evaluate whether maturational changes in respiratory rate can be determined by EMG analyses
|
5 consecutive days during first two weeks of life
|
|
Change of average value of heart rate over the measurement period
Time Frame: 5 consecutive days during first two weeks of life
|
To evaluate whether maturational changes in heart rate can be determined by EMG analyses
|
5 consecutive days during first two weeks of life
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sven Schulzke, Prof, University Children's Hospital Basel
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2015136
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.